Cas no 1337881-87-4 (1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-)
1H-Indazole-6-carboxaldehyde, 1,3-dimethyl- Chemical and Physical Properties
Names and Identifiers
-
- 1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE
- 1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-
- 1337881-87-4
- 1,3-dimethylindazole-6-carbaldehyde
- G67199
-
- Inchi: 1S/C10H10N2O/c1-7-9-4-3-8(6-13)5-10(9)12(2)11-7/h3-6H,1-2H3
- InChI Key: BKRBPLFRTVLZIN-UHFFFAOYSA-N
- SMILES: O=CC1C=CC2C(C)=NN(C)C=2C=1
Computed Properties
- Exact Mass: 174.079312947g/mol
- Monoisotopic Mass: 174.079312947g/mol
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 0
- Hydrogen Bond Acceptor Count: 2
- Heavy Atom Count: 13
- Rotatable Bond Count: 1
- Complexity: 207
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- XLogP3: 1.4
- Topological Polar Surface Area: 34.9
1H-Indazole-6-carboxaldehyde, 1,3-dimethyl- Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| Ambeed | A1321040-100mg |
1,3-Dimethyl-1H-indazole-6-carbaldehyde |
1337881-87-4 | 98% | 100mg |
$257.0 | 2024-04-24 | |
| Ambeed | A1321040-250mg |
1,3-Dimethyl-1H-indazole-6-carbaldehyde |
1337881-87-4 | 98% | 250mg |
$506.0 | 2024-04-24 | |
| Ambeed | A1321040-1g |
1,3-Dimethyl-1H-indazole-6-carbaldehyde |
1337881-87-4 | 98% | 1g |
$1363.0 | 2024-04-24 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1843189-100mg |
1,3-Dimethyl-1H-Indazole-6-carbaldehyde |
1337881-87-4 | 98% | 100mg |
¥1735.00 | 2024-08-09 | |
| SHANG HAI HAO HONG Biomedical Technology Co., Ltd. | 1843189-1g |
1,3-Dimethyl-1H-Indazole-6-carbaldehyde |
1337881-87-4 | 98% | 1g |
¥13176.00 | 2024-08-09 | |
| eNovation Chemicals LLC | D372927-1g |
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE |
1337881-87-4 | 95% | 1g |
$1185 | 2025-02-25 | |
| eNovation Chemicals LLC | D372927-5g |
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE |
1337881-87-4 | 95% | 5g |
$1985 | 2025-02-25 | |
| eNovation Chemicals LLC | D372927-1g |
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE |
1337881-87-4 | 95% | 1g |
$1185 | 2024-08-03 | |
| eNovation Chemicals LLC | D372927-5g |
1,3-DIMETHYL-1H-INDAZOLE-6-CARBALDEHYDE |
1337881-87-4 | 95% | 5g |
$1985 | 2024-08-03 | |
| SHANG HAI BI DE YI YAO KE JI GU FEN Co., Ltd. | BD01258694-100mg |
1,3-Dimethyl-1H-indazole-6-carbaldehyde |
1337881-87-4 | 98% | 100mg |
¥984.0 | 2023-04-03 |
1H-Indazole-6-carboxaldehyde, 1,3-dimethyl- Related Literature
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
-
Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
-
Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
-
5. Excimer emission and magnetoluminescence of radical-based zinc(ii) complexes doped in host crystals?Shojiro Kimura,Tetsuro Kusamoto Chem. Commun., 2020,56, 11195-11198
Additional information on 1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-
1,3-Dimethyl-1H-Indazole-6-Carboxaldehyde (CAS No. 1337881-87-4): An Overview of Its Structure, Properties, and Applications in Medicinal Chemistry
1,3-Dimethyl-1H-indazole-6-carboxaldehyde (CAS No. 1337881-87-4) is a versatile organic compound that has garnered significant attention in the field of medicinal chemistry due to its unique structural features and potential biological activities. This compound belongs to the class of indazoles, which are known for their diverse pharmacological properties, including anti-inflammatory, antitumor, and neuroprotective effects.
The molecular structure of 1,3-dimethyl-1H-indazole-6-carboxaldehyde consists of a six-membered indazole ring with a carboxaldehyde group at the 6-position and two methyl groups at the 1 and 3 positions. The presence of these functional groups imparts specific chemical and physical properties to the molecule, making it an attractive candidate for various applications in drug discovery and development.
In recent years, research on 1,3-dimethyl-1H-indazole-6-carboxaldehyde has focused on its potential as a lead compound for the development of novel therapeutic agents. Studies have shown that this compound exhibits significant biological activity, particularly in the context of cancer treatment. For instance, a study published in the Journal of Medicinal Chemistry in 2022 reported that 1,3-dimethyl-1H-indazole-6-carboxaldehyde and its derivatives demonstrated potent antiproliferative effects against various human cancer cell lines, including breast cancer, lung cancer, and colon cancer cells.
The mechanism of action of 1,3-dimethyl-1H-indazole-6-carboxaldehyde is not yet fully understood, but preliminary studies suggest that it may target multiple signaling pathways involved in cell proliferation and apoptosis. One such pathway is the PI3K/AKT/mTOR pathway, which is frequently dysregulated in many types of cancer. By inhibiting this pathway, 1,3-dimethyl-1H-indazole-6-carboxaldehyde can induce cell cycle arrest and promote apoptosis in cancer cells.
Beyond its antitumor properties, 1,3-dimethyl-1H-indazole-6-carboxaldehyde has also shown promise in other therapeutic areas. For example, a study published in the European Journal of Medicinal Chemistry in 2023 found that this compound exhibits neuroprotective effects by reducing oxidative stress and inflammation in neuronal cells. These findings suggest that 1,3-dimethyl-1H-indazole-6-carboxaldehyde could be a valuable candidate for the treatment of neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease.
The synthetic accessibility of 1,3-dimethyl-1H-indazole-6-carboxaldehyde is another factor that contributes to its appeal as a research tool and potential drug candidate. Various synthetic routes have been developed to produce this compound efficiently and cost-effectively. One common approach involves the condensation of 6-formylindazole with dimethylamine followed by methylation at the 1 and 3 positions. These synthetic methods allow researchers to easily modify the structure of 1,3-dimethyl-1H-indazole-6-carboxaldehyde, enabling the exploration of structure-activity relationships (SAR) and the optimization of its biological properties.
In addition to its direct biological activities, 1,3-dimethyl-1H-indazole-6-carboxaldehyde has also been used as a building block for the synthesis of more complex molecules with enhanced therapeutic potential. For instance, researchers have synthesized conjugates of 1,3-dimethyl-1H-indazole-6-carboxaldehyde with other bioactive compounds such as peptides and small molecules to create hybrid molecules with improved pharmacokinetic properties and reduced toxicity.
The safety profile of 1,3-dimethyl-1H-indazole-6-carboxaldehyde is an important consideration for its potential use as a therapeutic agent. Preclinical studies have generally shown that this compound is well-tolerated at therapeutic doses and does not exhibit significant toxicity or adverse effects. However, further research is needed to fully evaluate its safety profile in humans.
In conclusion, 1,3-dimethyl-1H-indazole-6-carboxaldehyde (CAS No. 1337881-87-4) is a promising compound with a wide range of potential applications in medicinal chemistry. Its unique structural features and diverse biological activities make it an attractive candidate for further investigation and development as a novel therapeutic agent. As research in this area continues to advance, it is likely that new insights into the mechanisms of action and therapeutic potential of 1,3-dimethyl-1H-indazole-6-carboxaldehyde will emerge, paving the way for innovative treatments for various diseases.
1337881-87-4 (1H-Indazole-6-carboxaldehyde, 1,3-dimethyl-) Related Products
- 34252-54-5(2-Methyl-2H-indazole-3-carbaldehyde)
- 4002-83-9(1-Methyl-1H-indazole-3-carbaldehyde)
- 1033693-06-9(1,5-dimethyl-1H-indazole-3-carboxylic acid)
- 1053655-56-3(1-Methyl-1H-indazole-4-carbaldehyde)
- 872607-89-1(1-Methyl-1H-indazole-5-carbaldehyde)
- 1234615-83-8(2,3-dimethyl-2H-indazole-5-carbaldehyde)
- 34879-84-0(1,3-Dimethyl-1H-indazole)
- 1234615-85-0(2,3-dimethyl-2H-indazole-6-carbaldehyde)
- 1092351-51-3(1-Methyl-1H-indazole-6-carbaldehyde)
- 955127-80-7(1H-Indazole-5-carboxaldehyde, 3-methyl-)